Skip to main content
SpringerLink
Log in

Rhadinoviruses: KSHV and Associated Malignancies

  • Chapter
  • First Online:
Cancer Associated Viruses

Part of the book series: Current Cancer Research ((CUCR))

  • 1270 Accesses

Abstract

Kaposi’s Sarcoma Herpesvirus (KSHV), discovered in 1994, is the only known Rhadinovirus (γ2-herpesvirus) to naturally infect humans. In addition to Kaposi’s Sarcoma (KS), one of the most common HIV-associated malignancies, KSHV is strongly associated with two rare lymphoproliferative disorders, namely, primary effusion lymphoma (PEL) and the plasmablastic variant of multicentric Castleman’s disease (MCD). Epidemiological arguments strongly link KSHV to KS and KSHV is found in endothelial spindle cells, the neoplastic component of KS. This tumour appears to be the result of an oligo/polyclonal expansion of atypically differentiated, but not fully transformed, endothelial cells accompanied by pronounced inflammatory and angiogenic features. The plasma cells variant of MCD is characterised by a proliferation of monotypic, KSHV-infected B-cell population with plasmablastic features. By contrast, PEL represents a monoclonal, fully transformed, malignant B-cell proliferation with the survival of PEL cells, depending on the presence of latent KSHV proteins. Co-factors such as immunosuppression, and perhaps also immune activation, play an important role in KSHV-induced oncogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • CDC (1981) Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men-New York City and California. MMWR 30(25):305–308

    Google Scholar 

  • Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I (2008) Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis 8:111

    PubMed  Google Scholar 

  • Alkharsah KR, Dedicoat M, Blasczyk R, Newton R, Schulz TF (2007) Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population. J Infect Dis 195(6):809–816

    PubMed  CAS  Google Scholar 

  • Andreoni M, Sarmati L, Nicastri E, El Sawaf G, El Zalabani M, Uccella I, Bugarini R, Parisi SG, Rezza G (2002) Primary human herpesvirus 8 infection in immunocompetent children. JAMA 287(10):1295–1300

    PubMed  Google Scholar 

  • Antman K, Chang Y (2000) Kaposi’s sarcoma. N Engl J Med 342(14):1027–1038

    PubMed  CAS  Google Scholar 

  • Aoki Y, Jaffe ES, Chang Y, Jones K, Teruya-Feldstein J, Moore PS, Tosato G (1999) Angiogenesis and hematopoiesis induced by Kaposi’s sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93(12):4034–4043

    PubMed  CAS  Google Scholar 

  • Aoki Y, Narazaki M, Kishimoto T, Tosato G (2001) Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus. Blood 98(10):3042–3049

    PubMed  CAS  Google Scholar 

  • Aoki Y, Tosato G (2007) Interactions between HIV-1 Tat and KSHV. Curr Top Microbiol Immunol 312:309–326

    PubMed  CAS  Google Scholar 

  • Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E (1997) Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385(6614):347–350

    PubMed  CAS  Google Scholar 

  • Ascoli V, Scalzo CC, Danese C, Vacca K, Pistilli A, Lo Coco F (1999) Human herpes virus-8 associated primary effusion lymphoma of the pleural cavity in HIV-negative elderly men. Eur Respir J 14(5):1231–1234

    PubMed  CAS  Google Scholar 

  • Ascoli V, Senis G, Zucchetto A, Valerio L, Facchinelli L, Budroni M, Dal Maso L, Coluzzi M (2009) Distribution of ‘promoter’ sandflies associated with incidence of classic Kaposi’s sarcoma. Med Vet Entomol 23(3):217–225

    PubMed  CAS  Google Scholar 

  • Atkinson JO, Biggar RJ, Goedert JJ, Engels EA (2004) The incidence of Kaposi sarcoma among injection drug users with AIDS in the United States (1999). J Acquir Immune Defic Syndr 37(2):1282–1287

    PubMed  Google Scholar 

  • Baillargeon J, Deng JH, Hettler E, Harrison C, Grady JJ, Korte LG, Alexander J, Montalvo E, Jenson HB, Gao SJ (2001) Seroprevalence of Kaposi’s sarcoma-associated herpesvirus infection among blood donors from Texas. Ann Epidemiol 11(7):512–518

    PubMed  CAS  Google Scholar 

  • Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S, Silverstein RL, Rafii S, Mesri EA (2003) Kaposi’s sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR. Cancer Cell 3(2):131–143

    PubMed  CAS  Google Scholar 

  • Beral V, Peterman TA, Berkelman RL, Jaffe HW (1990) Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335(8682):123–128

    PubMed  CAS  Google Scholar 

  • Berezne A, Agbalika F, Oksenhendler E (2004) Failure of cidofovir in HIV-associated multicentric Castleman disease. Blood 103(11):4368–4369, author reply 4369

    PubMed  CAS  Google Scholar 

  • Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F (2000) Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis 181(5):1562–1568

    PubMed  CAS  Google Scholar 

  • Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA, O’Leary JJ (1995) Kaposi’s sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1(12):1274–1278

    PubMed  CAS  Google Scholar 

  • Boulanger E, Gerard L, Gabarre J, Molina JM, Rapp C, Abino JF, Cadranel J, Chevret S, Oksenhendler E (2005) Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol 23(19):4372–4380

    PubMed  Google Scholar 

  • Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens-Part B: biological agents. Lancet Oncol 10(4):321–322

    PubMed  Google Scholar 

  • Bower M, Weir J, Francis N, Newsom-Davis T, Powles S, Crook T, Boffito M, Gazzard B, Nelson M (2009) The effect of HAART in 254 consecutive patients with AIDS-related Kaposi’s sarcoma. AIDS 23(13):1701–1706

    PubMed  Google Scholar 

  • Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, Brennan MF (1999) The management of unicentric and multicentric Castleman’s disease: a report of 16 cases and a review of the literature. Cancer 85(3):706–717

    PubMed  CAS  Google Scholar 

  • Brander C, Raje N, O’Connor PG, Davies F, Davis J, Chauhan D, Hideshima T, Martin J, Osmond D, Kedes DH, Walker BD, Scadden DT, Anderson KC (2002) Absence of biologically important Kaposi sarcoma-associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma. Blood 100(2):698–700

    PubMed  CAS  Google Scholar 

  • Brimo F, Michel RP, Khetani K, Auger M (2007) Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis. Cancer 111(4):224–233

    PubMed  Google Scholar 

  • Brinkmann MM, Pietrek M, Dittrich-Breiholz O, Kracht M, Schulz TF (2007) Modulation of host gene expression by the K15 protein of Kaposi’s sarcoma-associated herpesvirus. J Virol 81(1):42–58

    PubMed  CAS  Google Scholar 

  • Brown EE, Fallin D, Ruczinski I, Hutchinson A, Staats B, Vitale F, Lauria C, Serraino D, Rezza G, Mbisa G, Whitby D, Messina A, Goedert JJ, Chanock SJ (2006a) Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity. Cancer Epidemiol Biomarkers Prev 15(5):926–934

    PubMed  CAS  Google Scholar 

  • Brown EE, Whitby D, Vitale F, Marshall V, Mbisa G, Gamache C, Lauria C, Alberg AJ, Serraino D, Cordiali-Fei P, Messina A, Goedert JJ (2006b) Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer 107(9):2282–2290

    PubMed  CAS  Google Scholar 

  • Butler LM, Dorsey G, Hladik W, Rosenthal PJ, Brander C, Neilands TB, Mbisa G, Whitby D, Kiepiela P, Mosam A, Mzolo S, Dollard SC, Martin JN (2009) Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission. J Infect Dis 200(3):430–438

    PubMed  Google Scholar 

  • Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR (2005) Kaposi’s sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 102(15):5570–5575

    PubMed  CAS  Google Scholar 

  • Cancer ICoHa (2000) Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92(22):1823–1830

    Google Scholar 

  • Cannon MJ, Operskalski EA, Mosley JW, Radford K, Dollard SC (2009) Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort. J Infect Dis 199(11):1592–1598

    PubMed  Google Scholar 

  • Carbone A, Cilia AM, Gloghini A, Capello D, Perin T, Bontempo D, Canzonieri V, Tirelli U, Volpe R, Gaidano G (2000) Primary effusion lymphoma cell lines harbouring human herpesvirus type-8. Leuk Lymphoma 36(5–6):447–456

    PubMed  CAS  Google Scholar 

  • Carbone A, Gloghini A, Larocca LM, Capello D, Pierconti F, Canzonieri V, Tirelli U, Dalla-Favera R, Gaidano G (2001) Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 97(3):744–751

    PubMed  CAS  Google Scholar 

  • Carrieri MP, Pradier C, Piselli P, Piche M, Rosenthal E, Heudier P, Durant J, Serraino D (2003) Reduced incidence of Kaposi’s sarcoma and of systemic non-hodgkin’s lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer 103(1):142–144

    PubMed  CAS  Google Scholar 

  • Casper C (2006) Defining a role for antiviral drugs in the treatment of persons with HHV-8 infection. Herpes 13(2):42–47

    PubMed  CAS  Google Scholar 

  • Casper C, Carrell D, Miller KG, Judson FD, Meier AS, Pauk JS, Morrow RA, Corey L, Wald A, Celum C (2006) HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study. Sex Transm Infect 82(3):229–235

    PubMed  CAS  Google Scholar 

  • Casper C, Nichols WG, Huang ML, Corey L, Wald A (2004) Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 103(5):1632–1634

    PubMed  CAS  Google Scholar 

  • Cassar O, Afonso PV, Bassot S, Plancoulaine S, Duprez R, Capuano C, Abel M, Martin PM, Gessain A (2007) Novel human herpesvirus 8 subtype D strains in Vanuatu, Melanesia. Emerg Infect Dis 13(11):1745–1748

    PubMed  Google Scholar 

  • Cassar O, Bassot S, Plancoulaine S, Quintana-Murci L, Harmant C, Gurtsevitch V, Senyuta NB, Yakovleva LS, de The G, Gessain A (2010) Human herpesvirus 8, Southern Siberia. Emerg Infect Dis 16(3):580–582

    PubMed  Google Scholar 

  • Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9(4):822–830

    PubMed  CAS  Google Scholar 

  • Cattani P, Capuano M, Cerimele F, La Parola IL, Santangelo R, Masini C, Cerimele D, Fadda G (1999) Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi’s sarcoma. J Clin Microbiol 37(4):1150–1153

    PubMed  CAS  Google Scholar 

  • Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332(18):1186–1191

    PubMed  CAS  Google Scholar 

  • Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, Knowles DM (1996) Kaposi’s sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi’s sarcoma and malignant lymphoma. J Virol 70(11):8218–8223

    PubMed  CAS  Google Scholar 

  • Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266(5192):1865–1869

    PubMed  CAS  Google Scholar 

  • Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, Godden K, Paterson H, Weiss RA, Mittnacht S (1996) Cyclin encoded by KS herpesvirus. Nature 382(6590):410

    PubMed  CAS  Google Scholar 

  • Chatlynne LG, Ablashi DV (1999) Seroepidemiology of Kaposi’s sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol 9(3):175–185

    PubMed  CAS  Google Scholar 

  • Chen YB, Rahemtullah A, Hochberg E (2007) Primary effusion lymphoma. Oncologist 12(5):569–576

    PubMed  Google Scholar 

  • Cho MS, Choi HJ, Park HK, Cho SE, Han WS, Yang WI (2007) Questionable role of human herpesviruses in the pathogenesis of Kikuchi disease. Arch Pathol Lab Med 131(4):604–609

    PubMed  CAS  Google Scholar 

  • Choi J, Means RE, Damania B, Jung JU (2001) Molecular piracy of Kaposi’s sarcoma associated herpesvirus. Cytokine Growth Factor Rev 12(2–3):245–257

    PubMed  CAS  Google Scholar 

  • Cool CD, Rai PR, Yeager ME, Hernandez-Saavedra D, Serls AE, Bull TM, Geraci MW, Brown KK, Routes JM, Tuder RM, Voelkel NF (2003) Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med 349(12):1113–1122

    PubMed  CAS  Google Scholar 

  • Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, Manganaro D, Fasan M, Moroni M, Galli M, Parravicini C (2001) Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 98(12):3473–3475

    PubMed  CAS  Google Scholar 

  • Cunha AM, Caterino-de-Araujo A, Costa SC, Santos-Fortuna E, Boa-Sorte NC, Goncalves MS, Costa FF, Galvao-Castro B (2005) Increasing seroprevalence of human herpesvirus 8 (HHV-8) with age confirms HHV-8 endemicity in Amazon Amerindians from Brazil. J Gen Virol 86(Pt 9):2433–2437

    PubMed  CAS  Google Scholar 

  • Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, Russo A, Intrieri T, Vercelli M, Zambon P, Tagliabue G, Zanetti R, Federico M, Limina RM, Mangone L, De Lisi V, Stracci F, Ferretti S, Piffer S, Budroni M, Donato A, Giacomin A, Bellu F, Fusco M, Madeddu A, Vitarelli S, Tessandori R, Tumino R, Suligoi B, Franceschi S (2009) Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 100(5):840–847

    PubMed  CAS  Google Scholar 

  • Dargent JL, Lespagnard L, Sirtaine N, Cantinieaux B, Li R, Hermans P (2007) Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV-8)-positive multicentric Castleman’s disease and featuring a follicular growth pattern. APMIS 115(7):869–874

    PubMed  CAS  Google Scholar 

  • Davis MA, Sturzl MA, Blasig C, Schreier A, Guo HG, Reitz M, Opalenik SR, Browning PJ (1997) Expression of human herpesvirus 8-encoded cyclin D in Kaposi’s sarcoma spindle cells. J Natl Cancer Inst 89(24):1868–1874

    PubMed  CAS  Google Scholar 

  • De Clercq E (2003) Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev 16(4):569–596

    PubMed  Google Scholar 

  • de Sanjose S, Goedert JJ, Marshall V, Bellas C, Benavente Y, Bosch R, Domingo A, Fernandez de Sevilla A, Servitje O, Whitby D (2004) Risk of malignant lymphoma associated with human herpesvirus-8: a case-control study in Spain. Br J Cancer 90(11):2145–2148

    PubMed  Google Scholar 

  • de Sanjose S, Mbisa G, Perez-Alvarez S, Benavente Y, Sukvirach S, Hieu NT, Shin HR, Anh PT, Thomas J, Lazcano E, Matos E, Herrero R, Munoz N, Molano M, Franceschi S, Whitby D (2009) Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis 199(10):1449–1456

    PubMed  Google Scholar 

  • Dedicoat M, Newton R (2003) Review of the distribution of Kaposi’s sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi’s sarcoma. Br J Cancer 88(1):1–3

    PubMed  CAS  Google Scholar 

  • Dedicoat M, Newton R, Alkharsah KR, Sheldon J, Szabados I, Ndlovu B, Page T, Casabonne D, Gilks CF, Cassol SA, Whitby D, Schulz TF (2004) Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis 190(6):1068–1075

    PubMed  Google Scholar 

  • Dezube BJ, Krown SE, Lee JY, Bauer KS, Aboulafia DM (2006) Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi’s sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol 24(9):1389–1394

    PubMed  CAS  Google Scholar 

  • Di Alberti L, Piattelli A, Artese L, Favia G, Patel S, Saunders N, Porter SR, Scully CM, Ngui SL, Teo CG (1997) Human herpesvirus 8 variants in sarcoid tissues. Lancet 350(9092):1655–1661

    PubMed  Google Scholar 

  • Dictor M, Rambech E, Way D, Witte M, Bendsoe N (1996) Human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) DNA in Kaposi’s sarcoma lesions, AIDS Kaposi’s sarcoma cell lines, endothelial Kaposi’s sarcoma simulators, and the skin of immunosuppressed patients. Am J Pathol 148(6):2009–2016

    PubMed  CAS  Google Scholar 

  • DiGiovanna JJ, Safai B (1981) Kaposi’s sarcoma. Retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases. Am J Med 71(5):779–783

    PubMed  CAS  Google Scholar 

  • Dilnur P, Katano H, Wang ZH, Osakabe Y, Kudo M, Sata T, Ebihara Y (2001) Classic type of Kaposi’s sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Int 51(11):845–852

    PubMed  CAS  Google Scholar 

  • Dotti G, Fiocchi R, Motta T, Facchinetti B, Chiodini B, Borleri GM, Gavazzeni G, Barbui T, Rambaldi A (1999) Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia 13(5):664–670

    PubMed  CAS  Google Scholar 

  • Douglas JL, Gustin JK, Dezube B, Pantanowitz JL, Moses AV (2007) Kaposi’s sarcoma: a model of both malignancy and chronic inflammation. Panminerva Med 49(3):119–138

    PubMed  CAS  Google Scholar 

  • Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG (2001) Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97(7):2130–2136

    PubMed  CAS  Google Scholar 

  • Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95(4):1406–1412

    PubMed  CAS  Google Scholar 

  • Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C (1999) Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96(8):4546–4551

    PubMed  CAS  Google Scholar 

  • Dupin N, Grandadam M, Calvez V, Gorin I, Aubin JT, Havard S, Lamy F, Leibowitch M, Huraux JM, Escande JP et al (1995) Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi’s sarcoma. Lancet 345(8952):761–762

    PubMed  CAS  Google Scholar 

  • Dupont C, Vasseur E, Beauchet A, Aegerter P, Berthe H, de Truchis P, Zucman D, Rouveix E, Saiag P (2000) Long-term efficacy on Kaposi’s sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d’information et de soins de l’immunodeficience humaine. AIDS 14(8):987–993

    PubMed  CAS  Google Scholar 

  • Duprez R, Lacoste V, Briere J, Couppie P, Frances C, Sainte-Marie D, Kassa-Kelembho E, Lando MJ, Essame Oyono JL, Nkegoum B, Hbid O, Mahe A, Lebbe C, Tortevoye P, Huerre M, Gessain A (2007) Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma. J Natl Cancer Inst 99(14):1086–1094

    PubMed  CAS  Google Scholar 

  • Engels EA, Atkinson JO, Graubard BI, McQuillan GM, Gamache C, Mbisa G, Cohn S, Whitby D, Goedert JJ (2007) Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 196(2):199–207

    PubMed  Google Scholar 

  • Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, Wong-Staal F, Gallo RC (1989) AIDS-Kaposi’s sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243(4888):223–226

    PubMed  CAS  Google Scholar 

  • Fan W, Bubman D, Chadburn A, Harrington WJ Jr, Cesarman E, Knowles DM (2005) Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J Virol 79(2):1244–1251

    PubMed  CAS  Google Scholar 

  • Farge D (1993) Kaposi’s sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Eur J Med 2(6):339–343

    PubMed  CAS  Google Scholar 

  • Frances C, Mouquet C, Calvez V (1999) Human herpesvirus 8 and renal transplantation. N Engl J Med 340(13):1045, author reply 1046

    PubMed  CAS  Google Scholar 

  • Friborg J Jr, Kong W, Hottiger MO, Nabel GJ (1999) p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402(6764):889–894

    PubMed  CAS  Google Scholar 

  • Friedman-Kien AE (1981) Disseminated Kaposi’s sarcoma syndrome in young homosexual men. J Am Acad Dermatol 5(4):468–471

    PubMed  CAS  Google Scholar 

  • Fujimuro M, Hayward SD (2003) The latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J Virol 77(14):8019–8030

    PubMed  CAS  Google Scholar 

  • Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS (1996) KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med 2(8):925–928

    PubMed  CAS  Google Scholar 

  • Gaspari AA, Marchese S, Powell D, Rady PL, Tyring SK (1997) Identification of HHV-8 DNA in the skin lesions of Kaposi’s sarcoma in an immunosuppressed patient with bullous pemphigoid. J Am Acad Dermatol 37(5 Pt 2):843–847

    PubMed  CAS  Google Scholar 

  • Geddes M, Franceschi S, Barchielli A, Falcini F, Carli S, Cocconi G, Conti E, Crosignani P, Gafa L, Giarelli L et al (1994) Kaposi’s sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 69(2):333–336

    PubMed  CAS  Google Scholar 

  • George TI, Jones CD, Zehnder JL, Warnke RA, Dorfman RF (2003) Lack of human herpesvirus 8 and Epstein-Barr virus in Kikuchi’s histiocytic necrotizing lymphadenitis. Hum Pathol 34(2):130–135

    PubMed  Google Scholar 

  • Glesby MJ, Hoover DR, Weng S, Graham NM, Phair JP, Detels R, Ho M, Saah AJ (1996) Use of antiherpes drugs and the risk of Kaposi’s sarcoma: data from the Multicenter AIDS Cohort Study. J Infect Dis 173(6):1477–1480

    PubMed  CAS  Google Scholar 

  • Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA, Mittnacht S (1997) The cyclin encoded by Kaposi’s sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol 71(6):4193–4198

    PubMed  CAS  Google Scholar 

  • Godfrey A, Anderson J, Papanastasiou A, Takeuchi Y, Boshoff C (2005) Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 105(6):2510–2518

    PubMed  CAS  Google Scholar 

  • Goedert JJ, Calamusa G, Dazzi C, Perna A, Pelser C, Anderson LA, Madsen C, Preiss LR, Airola M, Graubard BI, Messina A, Lauria C, Romano N (2010) Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily. Infect Agent Cancer 5(1):23

    PubMed  Google Scholar 

  • Gompels UA, Kasolo FC (1996) HHV-8 serology and Kaposi’s sarcoma. Lancet 348(9041):1587–1588

    PubMed  CAS  Google Scholar 

  • Gottlieb GJ, Ragaz A, Vogel JV, Friedman-Kien A, Rywlin AM, Weiner EA, Ackerman AB (1981) A preliminary communication on extensively disseminated Kaposi’s sarcoma in young homosexual men. Am J Dermatopathol 3(2):111–114

    PubMed  CAS  Google Scholar 

  • Gottwein E, Cullen BR (2010) A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J Virol 84(10):5229–5237

    PubMed  CAS  Google Scholar 

  • Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR (2007) A viral microRNA functions as an orthologue of cellular miR-155. Nature 450(7172):1096–1099

    PubMed  CAS  Google Scholar 

  • Goudsmit J, Renwick N, Dukers NH, Coutinho RA, Heisterkamp S, Bakker M, Schulz TF, Cornelissen M, Weverling GJ (2000) Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984–1997): analysis of seroconversions to ORF65 and ORF73. Proc Natl Acad Sci USA 97(9):4838–4843

    PubMed  CAS  Google Scholar 

  • Grossmann C, Podgrabinska S, Skobe M, Ganem D (2006) Activation of NF-kappaB by the latent vFLIP gene of Kaposi’s sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J Virol 80(14):7179–7185

    PubMed  CAS  Google Scholar 

  • Grulich AE, Olsen SJ, Luo K, Hendry O, Cunningham P, Cooper DA, Gao SJ, Chang Y, Moore PS, Kaldor JM (1999) Kaposi’s sarcoma-associated herpesvirus: a sexually transmissible infection? J Acquir Immune Defic Syndr Hum Retrovirol 20(4):387–393

    PubMed  CAS  Google Scholar 

  • Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370(9581):59–67

    PubMed  Google Scholar 

  • Grundhoff A, Sullivan CS, Ganem D (2006) A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12(5):733–750

    PubMed  CAS  Google Scholar 

  • Guasparri I, Keller SA, Cesarman E (2004) KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med 199(7):993–1003

    PubMed  CAS  Google Scholar 

  • Guo HG, Pati S, Sadowska M, Charurat M, Reitz M (2004) Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J Virol 78(17):9336–9342

    PubMed  CAS  Google Scholar 

  • Guo HG, Sadowska M, Reid W, Tschachler E, Hayward G, Reitz M (2003) Kaposi’s sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J Virol 77(4):2631–2639

    PubMed  CAS  Google Scholar 

  • Hansen PB, Penkowa M, Kirk O, Skinhoj P, Pedersen C, Lisse I, Kiss K, Zhou X, Hamilton-Dutoit SJ (2000) Human immunodeficiency virus-associated malignant lymphoma in eastern Denmark diagnosed from 1990–1996: clinical features, histopathology, and association with Epstein-Barr virus and human herpesvirus-8. Eur J Haematol 64(6):368–375

    PubMed  CAS  Google Scholar 

  • Hayward GS (1999) KSHV strains: the origins and global spread of the virus. Semin Cancer Biol 9(3):187–199

    PubMed  CAS  Google Scholar 

  • Henke-Gendo C, Mengel M, Hoeper MM, Alkharsah K, Schulz TF (2005) Absence of Kaposi’s sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 172(12):1581–1585

    PubMed  Google Scholar 

  • Hladik W, Dollard SC, Mermin J, Fowlkes AL, Downing R, Amin MM, Banage F, Nzaro E, Kataaha P, Dondero TJ, Pellett PE, Lackritz EM (2006) Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 355(13):1331–1338

    PubMed  CAS  Google Scholar 

  • Hocqueloux L, Agbalika F, Oksenhendler E, Molina JM (2001) Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy. AIDS 15(2):280–282

    PubMed  CAS  Google Scholar 

  • Hoffman LJ, Bunker CH, Pellett PE, Trump DL, Patrick AL, Dollard SC, Keenan HA, Jenkins FJ (2004) Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer. J Infect Dis 189(1):15–20

    PubMed  Google Scholar 

  • Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E (1997) Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8. Blood 90(3):1186–1191

    PubMed  CAS  Google Scholar 

  • Huh J, Kang GH, Gong G, Kim SS, Ro JY, Kim CW (1998) Kaposi’s sarcoma-associated herpesvirus in Kikuchi’s disease. Hum Pathol 29(10):1091–1096

    PubMed  CAS  Google Scholar 

  • Hutt MS, Burkitt D (1965) Geographical distribution of cancer in East Africa: a new clinicopathological approach. Br Med J 2(5464):719–722

    PubMed  CAS  Google Scholar 

  • Jenkins FJ, Hayes RB, Jackson A, Pizza G, Mbisa G, Whitby D, Goedert JJ (2007) Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects. J Infect Dis 196(2):208–211

    PubMed  CAS  Google Scholar 

  • Jenner RG, Maillard K, Cattini N, Weiss RA, Boshoff C, Wooster R, Kellam P (2003) Kaposi’s sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci USA 100(18):10399–10404

    PubMed  CAS  Google Scholar 

  • Judde JG, Lacoste V, Briere J, Kassa-Kelembho E, Clyti E, Couppie P, Buchrieser C, Tulliez M, Morvan J, Gessain A (2000) Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi’s sarcoma and other diseases. J Natl Cancer Inst 92(9):729–736

    PubMed  CAS  Google Scholar 

  • Kaposi M (1872) Idiopathisches multiples Pigmentsarkomen der Haut. Arch Dermatol Syph 4:265–273

    Google Scholar 

  • Katano H, Ito K, Shibuya K, Saji T, Sato Y, Sata T (2005) Lack of human herpesvirus 8 infection in lungs of Japanese patients with primary pulmonary hypertension. J Infect Dis 191(5):743–745

    PubMed  Google Scholar 

  • Katsume A, Saito H, Yamada Y, Yorozu K, Ueda O, Akamatsu K, Nishimoto N, Kishimoto T, Yoshizaki K, Ohsugi Y (2002) Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman’s disease like symptoms emerged in IL-6 transgenic mice. Cytokine 20(6):304–311

    PubMed  CAS  Google Scholar 

  • Kazakov DV, Prinz BM, Michaelis S, Schmid M, Muller B, Adams V, Burg G, Kempf W (2002) Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi’s sarcoma, various mesenchymal tumors and related reactive conditions. J Cutan Pathol 29(5):279–281

    PubMed  Google Scholar 

  • Klaskala W, Brayfield BP, Kankasa C, Bhat G, West JT, Mitchell CD, Wood C (2005) Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia. J Med Virol 75(1):93–100

    PubMed  CAS  Google Scholar 

  • Klass CM, Krug LT, Pozharskaya VP, Offermann MK (2005) The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production. Blood 105(10):4028–4034

    PubMed  CAS  Google Scholar 

  • Klein U, Gloghini A, Gaidano G, Chadburn A, Cesarman E, Dalla-Favera R, Carbone A (2003) Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 101(10):4115–4121

    PubMed  CAS  Google Scholar 

  • Kliche S, Kremmer E, Hammerschmidt W, Koszinowski U, Haas J (1998) Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8. J Virol 72(10):8143–8149

    PubMed  CAS  Google Scholar 

  • Koon HB, Bubley GJ, Pantanowitz L, Masiello D, Smith B, Crosby K, Proper J, Weeden W, Miller TE, Chatis P, Egorin MJ, Tahan SR, Dezube BJ (2005) Imatinib-induced regression of AIDS-related Kaposi’s sarcoma. J Clin Oncol 23(5):982–989

    PubMed  CAS  Google Scholar 

  • Koopal S, Furuhjelm JH, Jarviluoma A, Jaamaa S, Pyakurel P, Pussinen C, Wirzenius M, Biberfeld P, Alitalo K, Laiho M, Ojala PM (2007) Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis. PLoS Pathog 3(9):1348–1360

    PubMed  CAS  Google Scholar 

  • Kouri V, Eng SM, Rodriguez ME, Resik S, Orraca O, Moore PS, Chang Y (2004) Seroprevalence of Kaposi’s sarcoma-associated herpesvirus in various populations in Cuba. Rev Panam de Salud Publica 15(5):320–325

    Google Scholar 

  • Lachant NA, Sun NC, Leong LA, Oseas RS, Prince HE (1985) Multicentric angiofollicular lymph node hyperplasia (Castleman’s disease) followed by Kaposi’s sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol 83(1):27–33

    PubMed  CAS  Google Scholar 

  • Lagunoff M, Lukac DM, Ganem D (2001) Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi’s sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication. J Virol 75(13):5891–5898

    PubMed  CAS  Google Scholar 

  • Lagunoff M, Majeti R, Weiss A, Ganem D (1999) Deregulated signal transduction by the K1 gene product of Kaposi’s sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 96(10):5704–5709

    PubMed  CAS  Google Scholar 

  • Laney AS, Cannon MJ, Jaffe HW, Offermann MK, Ou CY, Radford KW, Patel MM, Spira TJ, Gunthel CJ, Pellett PE, Dollard SC (2007) Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi’s sarcoma. AIDS 21(12):1541–1545

    PubMed  Google Scholar 

  • Lazzi S, Bellan C, Amato T, Palummo N, Cardone C, D’Amuri A, De Luca F, Beyanga M, Facchetti F, Tosi P, Leoncini L (2006) Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas? Hum Pathol 37(1):23–31

    PubMed  CAS  Google Scholar 

  • Lazzi S, Ferrari F, Nyongo A, Palummo N, de Milito A, Zazzi M, Leoncini L, Luzi P, Tosi P (1998) HIV-associated malignant lymphomas in Kenya (Equatorial Africa). Hum Pathol 29(11):1285–1289

    PubMed  CAS  Google Scholar 

  • Lebbe C, Agbalika F, Flageul B, Pellet C, Rybojad M, Cordoliani F, Farge D, Vignon-Pennamen MD, Sheldon J, Morel P, Calvo F, Schulz TF (1999) No evidence for a role of human herpesvirus type 8 in sarcoidosis: molecular and serological analysis. Br J Dermatol 141(3):492–496

    PubMed  CAS  Google Scholar 

  • Lee BS, Alvarez X, Ishido S, Lackner AA, Jung JU (2000) Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi’s sarcoma-associated herpesvirus K1. J Exp Med 192(1):11–21

    PubMed  CAS  Google Scholar 

  • Lee BS, Paulose-Murphy M, Chung YH, Connlole M, Zeichner S, Jung JU (2002) Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi’s sarcoma-associated herpesvirus by K1 signal transduction. J Virol 76(23):12185–12199

    PubMed  CAS  Google Scholar 

  • Lee H, Veazey R, Williams K, Li M, Guo J, Neipel F, Fleckenstein B, Lackner A, Desrosiers RC, Jung JU (1998) Deregulation of cell growth by the K1 gene of Kaposi’s sarcoma-associated herpesvirus. Nat Med 4(4):435–440

    PubMed  CAS  Google Scholar 

  • Lee JS, Li Q, Lee JY, Lee SH, Jeong JH, Lee HR, Chang H, Zhou FC, Gao SJ, Liang C, Jung JU (2009) FLIP-mediated autophagy regulation in cell death control. Nat Cell Biol 11(11):1355–1362

    PubMed  CAS  Google Scholar 

  • Lei X, Bai Z, Ye F, Xie J, Kim CG, Huang Y, Gao SJ (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12(2):193–199

    PubMed  CAS  Google Scholar 

  • Liang D, Gao Y, Lin X, He Z, Zhao Q, Deng Q, Lan K (2011) A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKvarepsilon. Cell Res. doi:10.1038/cr.2011.5

  • Lim SH, Beers SA, French RR, Johnson PW, Glennie MJ, Cragg MS (2010) Anti-CD20 monoclonal antibodies: historical and future perspectives. Haematologica 95(1):135–143

    PubMed  CAS  Google Scholar 

  • Little RF, Gutierrez M, Jaffe ES, Pau A, Horne M, Wilson W (2001) HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis. Jama 285(14):1880–1885

    PubMed  CAS  Google Scholar 

  • Liu C, Okruzhnov Y, Li H, Nicholas J (2001) Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects. J Virol 75(22):10933–10940

    PubMed  CAS  Google Scholar 

  • Liu L, Eby MT, Rathore N, Sinha SK, Kumar A, Chaudhary PM (2002) The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J Biol Chem 277(16):13745–13751

    PubMed  CAS  Google Scholar 

  • Luppi M, Barozzi P, Rasini V, Riva G, Re A, Rossi G, Setti G, Sandrini S, Facchetti F, Torelli G (2002) Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. Transplantation 74(1):131–132

    PubMed  Google Scholar 

  • Luppi M, Barozzi P, Schulz TF, Setti G, Staskus K, Trovato R, Narni F, Donelli A, Maiorana A, Marasca R, Sandrini S, Torelli G (2000) Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med 343(19):1378–1385

    PubMed  CAS  Google Scholar 

  • MacKenzie J, Sheldon J, Morgan G, Cook G, Schulz TF, Jarrett RF (1997) HHV-8 and multiple myeloma in the UK. Lancet 350(9085):1144–1145

    PubMed  CAS  Google Scholar 

  • Malope-Kgokong BI, Macphail P, Mbisa G, Ratshikhopha E, Maskew M, Stein L, Sitas F, Whitby D (2010) Kaposi’s Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa. Infect Agent Cancer 5:14

    PubMed  Google Scholar 

  • Mann DJ, Child ES, Swanton C, Laman H, Jones N (1999) Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi’s sarcoma-associated herpesvirus. EMBO J 18(3):654–663

    PubMed  CAS  Google Scholar 

  • Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH (1998) Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338(14):948–954

    PubMed  CAS  Google Scholar 

  • Matolcsy A, Nador RG, Cesarman E, Knowles DM (1998) Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am J Pathol 153(5):1609–1614

    PubMed  CAS  Google Scholar 

  • Mayama S, Cuevas LE, Sheldon J, Omar OH, Smith DH, Okong P, Silvel B, Hart CA, Schulz TF (1998) Prevalence and transmission of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 77(6):817–820

    PubMed  CAS  Google Scholar 

  • Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA (2003) Immune deficiency and risk for malignancy among persons with AIDS (1999). J Acquir Immune Defic Syndr 32(5):527–533

    PubMed  Google Scholar 

  • McCarthy W, Pack GT (1950) Malignant blood vessel tumors; a report of 56 cases of angiosarcoma and Kaposi’s sarcoma. Surg Gynecol Obstet 91(4):465–482

    PubMed  CAS  Google Scholar 

  • Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, Ebbesen P, Schulz TF (1998) Risk factors for Kaposi’s-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981–1996. Int J Cancer 77(4):543–548

    PubMed  CAS  Google Scholar 

  • Memar OM, Rady PL, Goldblum RM, Yen A, Tyring SK (1997) Human herpesvirus 8 DNA sequences in blistering skin from patients with pemphigus. Arch Dermatol 133(10):1247–1251

    PubMed  CAS  Google Scholar 

  • Mesri EA, Cesarman E, Boshoff C (2010) Kaposi’s sarcoma and its associated herpesvirus. Nat Rev 10(10):707–719

    CAS  Google Scholar 

  • Mikala G, Xie J, Berencsi G, Kiss C, Marton I, Domjan G, Valyi-Nagy I (1999) Human herpesvirus 8 in hematologic diseases. Pathol Oncol Res 5(1):73–79

    PubMed  CAS  Google Scholar 

  • Minhas V, Brayfield BP, Crabtree KL, Kankasa C, Mitchell CD, Wood C (2010) Primary gamma-herpesviral infection in Zambian children. BMC Infect Dis 10:115

    PubMed  Google Scholar 

  • Mohanna S, Maco V, Bravo F, Gotuzzo E (2005) Epidemiology and clinical characteristics of classic Kaposi’s sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. Int J Infect Dis 9(5):239–250

    PubMed  Google Scholar 

  • Mohanna S, Portillo JA, Carriquiry G, Vidal J, Ferrufino JC, Sanchez J, Bravo F, Gotuzzo E (2007) Human herpesvirus-8 in Peruvian blood donors: a population with hyperendemic disease? Clin Infect Dis 44(4):558–561

    PubMed  Google Scholar 

  • Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y, Li Y, Ray PE, Gutkind JS (2003) Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi’s sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3(1):23–36

    PubMed  CAS  Google Scholar 

  • Montaner S, Sodhi A, Pece S, Mesri EA, Gutkind JS (2001) The Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res 61(6):2641–2648

    PubMed  CAS  Google Scholar 

  • Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, Parry JP, Conley LJ, Jaffe HW, Chang Y (1996) Kaposi’s sarcoma-associated herpesvirus infection prior to onset of Kaposi’s sarcoma. AIDS 10(2):175–180

    PubMed  CAS  Google Scholar 

  • Moray G, Basaran O, Yagmurdur MC, Emiroglu R, Bilgin N, Haberal M (2004) Immunosuppressive therapy and Kaposi’s sarcoma after kidney transplantation. Transplant Proc 36(1):168–170

    PubMed  CAS  Google Scholar 

  • Mori Y, Nishimoto N, Ohno M, Inagi R, Dhepakson P, Amou K, Yoshizaki K, Yamanishi K (2000) Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion. J Med Virol 61(3):332–335

    PubMed  CAS  Google Scholar 

  • Mylona EE, Baraboutis IG, Lekakis LJ, Georgiou O, Papastamopoulos V, Skoutelis A (2008) Multicentric Castleman’s disease in HIV infection: a systematic review of the literature. AIDS Rev 10(1):25–35

    PubMed  Google Scholar 

  • Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood 88(2):645–656

    PubMed  CAS  Google Scholar 

  • Neipel F, Albrecht JC, Ensser A, Huang YQ, Li JJ, Friedman-Kien AE, Fleckenstein B (1997) Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 71(1):839–842

    PubMed  CAS  Google Scholar 

  • Newton R, Carpenter L, Casabonne D, Beral V, Babiker A, Darbyshire J, Weller I, Weiss R, Kwan A, Bourboulia D, Munoz F, Lagos D, Boshoff C (2006) A prospective study of Kaposi’s sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1. Br J Cancer 94(10):1504–1509

    PubMed  CAS  Google Scholar 

  • Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C (2003) Infection with Kaposi’s sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi’s sarcoma in Uganda. Br J Cancer 89(3):502–504

    PubMed  CAS  Google Scholar 

  • Nickoloff BJ (1991) The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi’s sarcoma. Arch Dermatol 127(4):523–529

    PubMed  CAS  Google Scholar 

  • Nickoloff BJ (1993) PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells, and dermal dendrocytes in Kaposi’s sarcoma. Arch Dermatol 129(2):250–251

    PubMed  CAS  Google Scholar 

  • Nicoli P, Familiari U, Bosa M, Allice T, Mete F, Morotti A, Cilloni D, Saglio G, Guerrasio A (2009) HHV8-positive, HIV-negative multicentric Castleman’s disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. Int J Hematol 90(3):392–396

    PubMed  CAS  Google Scholar 

  • Nishimoto N, Sasai M, Shima Y, Nakagawa M, Matsumoto T, Shirai T, Kishimoto T, Yoshizaki K (2000) Improvement in Castleman’s disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95(1):56–61

    PubMed  CAS  Google Scholar 

  • O’Brien TR, Kedes D, Ganem D, Macrae DR, Rosenberg PS, Molden J, Goedert JJ (1999) Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi’s sarcoma. J Infect Dis 180(4):1010–1017

    PubMed  Google Scholar 

  • Ojala PM, Yamamoto K, Castanos-Velez E, Biberfeld P, Korsmeyer SJ, Makela TP (2000) The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol 2(11):819–825

    PubMed  CAS  Google Scholar 

  • Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99(7):2331–2336

    PubMed  CAS  Google Scholar 

  • Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel JP, Agbalika F (2000) High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 96(6):2069–2073

    PubMed  CAS  Google Scholar 

  • Oksenhendler E, Cazals-Hatem D, Schulz TF, Barateau V, Grollet L, Sheldon J, Clauvel JP, Sigaux F, Agbalika F (1998) Transient angiolymphoid hyperplasia and Kaposi’s sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med 338(22):1585–1590

    PubMed  CAS  Google Scholar 

  • Osborne J, Moore PS, Chang Y (1999) KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol 60(10):921–927

    PubMed  CAS  Google Scholar 

  • Parravicini C, Chandran B, Corbellino M, Berti E, Paulli M, Moore PS, Chang Y (2000) Differential viral protein expression in Kaposi’s sarcoma-associated herpesvirus-infected diseases: Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. Am J Pathol 156(3):743–749

    PubMed  CAS  Google Scholar 

  • Parravicini C, Olsen SJ, Capra M, Poli F, Sirchia G, Gao SJ, Berti E, Nocera A, Rossi E, Bestetti G, Pizzuto M, Galli M, Moroni M, Moore PS, Corbellino M (1997) Risk of Kaposi’s sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi’s sarcoma patients. Blood 90(7):2826–2829

    PubMed  CAS  Google Scholar 

  • Pati S, Cavrois M, Guo HG, Foulke JS Jr, Kim J, Feldman RA, Reitz M (2001) Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi’s sarcoma pathogenesis. J Virol 75(18):8660–8673

    PubMed  CAS  Google Scholar 

  • Pelser C, Dazzi C, Graubard BI, Lauria C, Vitale F, Goedert JJ (2009) Risk of classic Kaposi sarcoma with residential exposure to volcanic and related soils in Sicily. Ann Epidemiol 19(8):597–601

    PubMed  Google Scholar 

  • Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grasser FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2(4):269–276

    PubMed  CAS  Google Scholar 

  • Plancoulaine S, Abel L, van Beveren M, Tregouet DA, Joubert M, Tortevoye P, de The G, Gessain A (2000) Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356(9235):1062–1065

    PubMed  CAS  Google Scholar 

  • Prakash O, Tang ZY, Peng X, Coleman R, Gill J, Farr G, Samaniego F (2002) Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene. J Natl Cancer Inst 94(12):926–935

    PubMed  CAS  Google Scholar 

  • Preiser W, Szep NI, Lang D, Doerr HW, Rabenau HF (2001) Kaposi’s sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems. Med Microbiol Immunol 190(3):121–127

    PubMed  CAS  Google Scholar 

  • Qian LW, Xie J, Ye F, Gao SJ (2007) Kaposi’s sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases. J Virol 81(13):7001–7010

    PubMed  CAS  Google Scholar 

  • Qin Z, Kearney P, Plaisance K, Parsons CH (2009) Pivotal Advance: Kaposi’s sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukoc Biol 87(1):25–34

    Google Scholar 

  • Qunibi W, Al-Furayh O, Almeshari K, Lin SF, Sun R, Heston L, Ross D, Rigsby M, Miller G (1998) Serologic association of human herpesvirus eight with posttransplant Kaposi’s sarcoma in Saudi Arabia. Transplantation 65(4):583–585

    PubMed  CAS  Google Scholar 

  • Radkov SA, Kellam P, Boshoff C (2000) The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6(10):1121–1127

    PubMed  CAS  Google Scholar 

  • Regamey N, Tamm M, Wernli M, Witschi A, Thiel G, Cathomas G, Erb P (1998) Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 339(19):1358–1363

    PubMed  CAS  Google Scholar 

  • Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J (1998) Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi’s sarcoma. AIDS (London, England) 12(18):2481–2488

    CAS  Google Scholar 

  • Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR (1997) Kaposi’s sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276(5320):1851–1854

    PubMed  CAS  Google Scholar 

  • Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristera R, Aiuti F, Ortona L, Ensoli B (1999) Human herpesvirus 8 seropositivity and risk of Kaposi’s sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst 91(17):1468–1474

    PubMed  CAS  Google Scholar 

  • Rezza G, Danaya RT, Wagner TM, Sarmati L, Owen IL, Monini P, Andreoni M, Suligoi B, Ensoli B, Pozio E (2001) Human herpesvirus-8 and other viral infections, Papua New Guinea. Emerg Infect Dis 7(5):893–895

    PubMed  CAS  Google Scholar 

  • Riva G, Barozzi P, Torelli G, Luppi M (2010) Immunological and inflammatory features of Kaposi’s sarcoma and other Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias. AIDS Rev 12(1):40–51

    PubMed  Google Scholar 

  • Rywlin AM, Rosen L, Cabello B (1983) Coexistence of Castleman’s disease and Kaposi’s sarcoma. Report of a case and a speculation. Am J Dermatopathol 5(3):277–281

    PubMed  CAS  Google Scholar 

  • Safai B, Good RA (1981) Kaposi’s sarcoma: a review and recent developments. CA Cancer J Clin 31(1):2–12

    PubMed  CAS  Google Scholar 

  • Said JW, Rettig MR, Heppner K, Vescio RA, Schiller G, Ma HJ, Belson D, Savage A, Shintaku IP, Koeffler HP, Asou H, Pinkus G, Pinkus J, Schrage M, Green E, Berenson JR (1997) Localization of Kaposi’s sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 90(11):4278–4282

    PubMed  CAS  Google Scholar 

  • Sakakibara S, Pise-Masison CA, Brady JN, Tosato G (2009) Gene regulation and functional alterations induced by Kaposi’s sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells. J Virol 83(5):2140–2153

    PubMed  CAS  Google Scholar 

  • Salahuddin SZ, Nakamura S, Biberfeld P, Kaplan MH, Markham PD, Larsson L, Gallo RC (1988) Angiogenic properties of Kaposi’s sarcoma-derived cells after long-term culture in vitro. Science 242(4877):430–433

    PubMed  CAS  Google Scholar 

  • Sarek G, Jarviluoma A, Moore HM, Tojkander S, Vartia S, Biberfeld P, Laiho M, Ojala PM (2011) Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency. PLoS Pathog 6(3):e1000818

    Google Scholar 

  • Sarek G, Jarviluoma A, Ojala PM (2006) KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas. Blood 107(2):725–732

    PubMed  CAS  Google Scholar 

  • Sarek G, Kurki S, Enback J, Iotzova G, Haas J, Laakkonen P, Laiho M, Ojala PM (2007) Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. J Clin Invest 117(4):1019–1028

    PubMed  CAS  Google Scholar 

  • Sharma-Walia N, Paul AG, Bottero V, Sadagopan S, Veettil MV, Kerur N, Chandran B (2010) Kaposi’s sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog 6(2):e1000777

    PubMed  Google Scholar 

  • Shin YC, Nakamura H, Liang X, Feng P, Chang H, Kowalik TF, Jung JU (2006) Inhibition of the ATM/p53 signal transduction pathway by Kaposi’s sarcoma-associated herpesvirus interferon regulatory factor 1. J Virol 80(5):2257–2266

    PubMed  CAS  Google Scholar 

  • Si H, Robertson ES (2006) Kaposi’s sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function. J Virol 80(2):697–709

    PubMed  CAS  Google Scholar 

  • Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Jentsch U, Pacella-Norman R, Bourboulia D, Whitby D, Boshoff C, Weiss R (1999) Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 340(24):1863–1871

    PubMed  CAS  Google Scholar 

  • Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R (2007) Kaposi’s sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81(23):12836–12845

    PubMed  CAS  Google Scholar 

  • Slavin G, Cameron HM, Forbes C, Mitchell RM (1970) Kaposi’s sarcoma in East African children: a report of 51 cases. J Pathol 100(3):187–199

    PubMed  CAS  Google Scholar 

  • Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, Gutkind JS (2000) The Kaposi’s sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 60(17):4873–4880

    PubMed  CAS  Google Scholar 

  • Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d’Agay MF, Clauvel JP, Raphael M, Degos L et al (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86(4):1276–1280

    PubMed  CAS  Google Scholar 

  • Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G (2005) Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 352(13):1317–1323

    PubMed  CAS  Google Scholar 

  • Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT (1997) Kaposi’s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71(1):715–719

    PubMed  CAS  Google Scholar 

  • Stein L, Urban MI, O’Connell D, Yu XQ, Beral V, Newton R, Ruff P, Donde B, Hale M, Patel M, Sitas F (2008) The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995–2004. Int J Cancer 122(10):2260–2265

    PubMed  CAS  Google Scholar 

  • Suthaus J, Adam N, Grotzinger J, Scheller J, Rose-John S (2010) Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization. Eur J Cell Biol 90(6–7):495–504

    PubMed  Google Scholar 

  • Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N (1997) Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390(6656):184–187

    PubMed  CAS  Google Scholar 

  • Tessari G, Naldi L, Boschiero L, Cordiano C, Piaserico S, Fortina AB, Cerimele D, La Parola IL, Capuano M, Gotti E, Ruggenenti P, Sassi F, Remuzzi G, Girolomoni G (2006) Incidence and clinical predictors of Kaposi’s sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. Eur J Dermatol 16(5):553–557

    PubMed  Google Scholar 

  • Tomlinson CC, Damania B (2004) The K1 protein of Kaposi’s sarcoma-associated herpesvirus activates the Akt signaling pathway. J Virol 78(4):1918–1927

    PubMed  CAS  Google Scholar 

  • Tye MJ (1970) Bullous pemphigoid and Kaposi’s sarcoma. Arch Dermatol 101(6):690–691

    PubMed  CAS  Google Scholar 

  • Uldrick TS, Wang V, O’Mahony D, Aleman K, Wyvill KM, Marshall V, Steinberg SM, Pittaluga S, Maric I, Whitby D, Tosato G, Little RF, Yarchoan R (2010) An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis 51(3):350–358

    PubMed  CAS  Google Scholar 

  • Ustun C, Reid-Nicholson M, Nayak-Kapoor A, Jones-Crawford J, McDonald K, Jillella AP, Ramalingam P (2009) Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome. Ann Hematol 88(4):351–358

    PubMed  Google Scholar 

  • Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE (2006) Cancer incidence before and after kidney transplantation. Jama 296(23):2823–2831

    PubMed  CAS  Google Scholar 

  • Vamvakas EC (2010) Is human herpesvirus-8 transmitted by transfusion? Transfus Med Rev 24(1):1–14

    PubMed  Google Scholar 

  • van Kooten C, Rensink I, Aarden L, van Oers R (1993) Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells. Leukemia 7(4):618–624

    PubMed  Google Scholar 

  • Verma SC, Lan K, Robertson E (2007) Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol 312:101–136

    PubMed  CAS  Google Scholar 

  • Verschuren EW, Klefstrom J, Evan GI, Jones N (2002) The oncogenic potential of Kaposi’s sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2(3):229–241

    PubMed  CAS  Google Scholar 

  • Vieira J, Huang ML, Koelle DM, Corey L (1997) Transmissible Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi’s sarcoma. J Virol 71(9):7083–7087

    PubMed  CAS  Google Scholar 

  • Viejo-Borbolla A, Ottinger M, Bruning E, Burger A, Konig R, Kati E, Sheldon JA, Schulz TF (2005) Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi’s Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J Virol 79(21):13618–13629

    PubMed  CAS  Google Scholar 

  • Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Makinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C (2004a) Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36(7):687–693

    PubMed  CAS  Google Scholar 

  • Wang L, Damania B (2008) Kaposi’s sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res 68(12):4640–4648

    PubMed  CAS  Google Scholar 

  • Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B (2006) Immortalization of primary endothelial cells by the K1 protein of Kaposi’s sarcoma-associated herpesvirus. Cancer Res 66(7):3658–3666

    PubMed  CAS  Google Scholar 

  • Wang L, Wakisaka N, Tomlinson CC, DeWire SM, Krall S, Pagano JS, Damania B (2004b) The Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res 64(8):2774–2781

    PubMed  CAS  Google Scholar 

  • Wang QJ, Jenkins FJ, Jacobson LP, Kingsley LA, Day RD, Zhang ZW, Meng YX, Pellett PE, Kousoulas KG, Baghian A, Rinaldo CR Jr (2001) Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. Blood 97(8):2366–2373

    PubMed  CAS  Google Scholar 

  • Wang S, Wang S, Maeng H, Young DP, Prakash O, Fayad LE, Younes A, Samaniego F (2007) K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis. Blood 109(5):2174–2182

    PubMed  CAS  Google Scholar 

  • Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS et al (1995) Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet 346(8978):799–802

    PubMed  CAS  Google Scholar 

  • Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G (1998) Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 90(5):395–397

    PubMed  CAS  Google Scholar 

  • Whitby D, Luppi M, Sabin C, Barozzi P, Di Biase AR, Balli F, Cucci F, Weiss RA, Boshoff C, Torelli G (2000) Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission. Br J Cancer 82(3):702–704

    PubMed  CAS  Google Scholar 

  • Whitby D, Marshall VA, Bagni RK, Miley WJ, McCloud TG, Hines-Boykin R, Goedert JJ, Conde BA, Nagashima K, Mikovits J, Dittmer DP, Newman DJ (2007) Reactivation of Kaposi’s sarcoma-associated herpesvirus by natural products from Kaposi’s sarcoma endemic regions. Int J Cancer 120(2):321–328

    PubMed  CAS  Google Scholar 

  • Whitby D, Marshall VA, Bagni RK, Wang CD, Gamache CJ, Guzman JR, Kron M, Ebbesen P, Biggar RJ (2004) Genotypic characterization of Kaposi’s sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. J Gen Virol 85(Pt 1):155–163

    PubMed  CAS  Google Scholar 

  • Wies E, Mori Y, Hahn A, Kremmer E, Sturzl M, Fleckenstein B, Neipel F (2008) The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. Blood 111(1):320–327

    PubMed  CAS  Google Scholar 

  • Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T et al (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease. Blood 74(4):1360–1367

    PubMed  CAS  Google Scholar 

  • Zanetti E, Barozzi P, Brown EE, Bosco R, Vallerini D, Riva G, Quadrelli C, Potenza L, Forghieri F, Montagnani G, D’Amico R, Del Giovane C, Duraes C, Whitby D, Machado JC, Schulz TF, Torelli G, Luppi M (2010) Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. Transplantation 90(3):337–338

    PubMed  Google Scholar 

  • Zavos G, Bokos J, Papaconstantinou I, Boletis J, Gazouli M, Kakisis J, Zografidis A, Kostakis A (2004) Clinicopathological aspects of 18 Kaposi’s sarcoma among 1055 Greek renal transplant recipients. Artif Organs 28(6):595–599

    PubMed  Google Scholar 

  • Zeng Y, Zhang X, Huang Z, Cheng L, Yao S, Qin D, Chen X, Tang Q, Lv Z, Zhang L, Lu C (2007) Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi’s sarcoma-associated herpesvirus: role of JAK/STAT signaling. J Virol 81(5):2401–2417

    PubMed  CAS  Google Scholar 

  • Ziegler JL, Katongole-Mbidde E (1996) Kaposi’s sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer 65(2):200–203

    PubMed  CAS  Google Scholar 

  • Zong JC, Ciufo DM, Alcendor DJ, Wan X, Nicholas J, Browning PJ, Rady PL, Tyring SK, Orenstein JM, Rabkin CS, Su IJ, Powell KF, Croxson M, Foreman KE, Nickoloff BJ, Alkan S, Hayward GS (1999) High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi’s sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 73(5):4156–4170

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Virology, Hannover Medical School, Hannover, Germany

    Susann Santag & Thomas F. Schulz

Authors
  1. Susann Santag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas F. Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas F. Schulz .

Editor information

Editors and Affiliations

  1. Perelman School of Medicine, University of Pennsylvania, Hamilton Walk 3610, Philadelphia, 19104, Pennsylvania, USA

    Erle S. Robertson

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Santag, S., Schulz, T.F. (2012). Rhadinoviruses: KSHV and Associated Malignancies. In: Robertson, E. (eds) Cancer Associated Viruses. Current Cancer Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0016-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-0016-5_10

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-9999-3

  • Online ISBN: 978-1-4614-0016-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation